Hua Ren Pharmaceutical Co., Ltd.

Announcement on Progress of Providing Guarantee for Subsidiary

Legal Opinion from Beijing Zhide (Qingdao) Law Firm on the 2025 Annual Shareholders' Meeting of Huarun Pharmaceutical Co., Ltd.

Announcement of the Resolutions of the 14th (Temporary) Meeting of the 8th Board of Directors

Announcement of the Resolutions of the 2025 Annual Shareholders' Meeting

Announcement on Changes in Senior Management Personnel

Announcement on the Progress of Providing Guarantees for Subsidiaries

Announcement on the progress of providing guarantees for subsidiaries

Announcement on the Progress of Major Litigation

Announcement on the Renewal of the Audit Institution for 2026

Outline of the Strategic Development Plan for Huaren Pharmaceutical Co., Ltd. for the Next Three Years (2026-2028)

Announcement on Uncovered Losses Reaching One-Third of the Total Paid-in Capital

Independent Director Work Report for 2025 (Liu Yong)

Independent Director Work Report for 2025 (Wang Zhenjie)

Independent Director Work Report for 2025 (Zhang Tianxi, resigned)

Independent Director Work Report for 2025 (Fan Yingjie)

Independent Director Work Report for 2025 (Feng Genfu, resigned)

Announcement on Participation in the 2026 Online Collective Reception Day for Investors of Listed Companies in the Qingdao Area and the 2025 Annual Performance Briefing

Internal Control Audit Report

Self-Evaluation Report on Internal Control for 2025

Announcement on Changes in Accounting Policies

Announcement on the Provision for Asset Impairment and Write-off of Assets for 2025

Announcement on Cumulative Litigation and Arbitration Situations

Announcement on Changes in Senior Management

Announcement on Applying for Comprehensive Credit from Banks and the Company's Guarantees for Subsidiaries and Subsidiaries' Guarantees for the Company

Notice of the 2025 Annual Shareholders' Meeting

Announcement of the Resolutions of the 13th Meeting of the 8th Board of Directors

Announcement on the Proposal Not to Distribute Profits for 2025

Q1 Report for 2026

Special Audit Opinion from Zhongxinghua Accounting Firm (Special General Partnership) on the Company's 2025 Operating Revenue Deduction

Evaluation Report on the Accounting Firm's Performance in 2025

Report of the Audit Committee of the Board on the Supervision of the Accounting Firm's Performance in 2025